Content strategy for startups under 20 people for healthcare and life sciences in the Middle East
How under-20-person startups get content strategy live without hiring — the specific version of the playbook designed for constraint. Written for commercial leaders at healthtech, medtech, and life-sciences companies in the Middle East.
This edition of the Growth Broker playbook is written for commercial leaders at healthtech, medtech, and life-sciences companies operating in the Middle East. In this market, Middle Eastern buyers reward in-person credibility, sovereign fit, and patient sequencing, so the way you install content strategy has to be shaped to that reality from day one.
The under-20-person version of content strategy is not a diluted enterprise playbook. It is publishing what your buyer needs to move a decision, not what the CMS quota demands with different constraints: no headcount, no politics, and no time to be wrong for long.
Own it personally as a founder or lean-in operator for the first quarter. Hiring a specialist too early replaces context with process.
Pick one channel, one trigger, one message. Two of anything at this stage is too many and none of them will work.
Inside healthcare and life sciences, the binding constraint is almost always regulated-sale cycle length, not intent, and in the Middle East it is compounded by the fact that senior-relationship access, not product is what actually gates growth. Content strategy is only useful here when it is pointed at both constraints at once.
Instrument pieces cited by prospects during sales calls in a spreadsheet if you have to. Legibility beats sophistication under 20 people.
The startup-specific trap is confusing volume with authority, usually because a well-meaning advisor points at what worked at their $50m company. Ignore.
Budget rules: whatever you spend on tools, spend the same on the person operating them. Under-tooling is fine; under-humaning is not.
A working content strategy function at 15 people is a genuine moat — most competitors of that size do not have one, and the discipline carries forward as the company grows.
Concretely for healthcare and life sciences in the Middle East: the healthcare teams that install this get past procurement instead of dying in it, and one sovereign or family-office win in the Middle East justifies a full year of program spend. That is the reason it is worth installing content strategy deliberately for this market rather than importing a playbook designed for somewhere else.
Frequently asked questions
Content · healthcare · Middle East — answered
- Does content strategy work for healthcare and life sciences in the Middle East?
- Yes — provided it is pointed at regulated-sale cycle length, not intent and adapted to the fact that in the Middle East, Middle Eastern buyers reward in-person credibility, sovereign fit, and patient sequencing. The healthcare teams that install this get past procurement instead of dying in it.
- Can a five-person team run content strategy?
- Yes, if the founder owns it. The lower headcount, the more concentrated the ownership.
- What is the smallest useful content strategy setup?
- One channel, one trigger, one message, and a spreadsheet tracking pieces cited by prospects during sales calls.
- Should we hire a specialist for content strategy?
- Not in the first quarter. Own it personally until the model is proven.
- What common advice should startups ignore?
- Anything derived from a company more than 10x larger. Constraints differ.
- What is the Middle East-specific pitfall when running content strategy for healthcare?
- Importing a playbook that was built for another market. In the Middle East, Middle Eastern buyers reward in-person credibility, sovereign fit, and patient sequencing — the install has to reflect that.
Growth Broker editorial
Filed under content · healthcare · middle east